These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

752 related items for PubMed ID: 11533711

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. CD1d-restricted NKT regulatory cells: functional genomic analyses provide new insights into the mechanisms of protection against Type 1 diabetes.
    Mi QS, Meagher C, Delovitch TL.
    Novartis Found Symp; 2003; 252():146-60; discussion 160-4, 203-10. PubMed ID: 14609217
    [Abstract] [Full Text] [Related]

  • 4. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo.
    Chamoto K, Takeshima T, Kosaka A, Tsuji T, Matsuzaki J, Togashi Y, Ikeda H, Nishimura T.
    Immunol Lett; 2004 Aug 15; 95(1):5-11. PubMed ID: 15325792
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
    Kawakami K, Kinjo Y, Yara S, Uezu K, Koguchi Y, Tohyama M, Azuma M, Takeda K, Akira S, Saito A.
    Infect Immun; 2001 Nov 15; 69(11):6643-50. PubMed ID: 11598033
    [Abstract] [Full Text] [Related]

  • 9. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.
    Ueda N, Kuki H, Kamimura D, Sawa S, Seino K, Tashiro T, Fushuku K, Taniguchi M, Hirano T, Murakami M.
    Int Immunol; 2006 Sep 15; 18(9):1397-404. PubMed ID: 16914507
    [Abstract] [Full Text] [Related]

  • 10. Regulation of immune responses by natural killer T cells.
    Sharif S, Delovitch TL.
    Arch Immunol Ther Exp (Warsz); 2001 Sep 15; 49 Suppl 1():S23-31. PubMed ID: 11603866
    [Abstract] [Full Text] [Related]

  • 11. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
    Hayakawa Y, Takeda K, Yagita H, Kakuta S, Iwakura Y, Van Kaer L, Saiki I, Okumura K.
    Eur J Immunol; 2001 Jun 15; 31(6):1720-7. PubMed ID: 11385616
    [Abstract] [Full Text] [Related]

  • 12. Effects of cyclosporin A on the activation of natural killer T cells induced by alpha-galactosylceramide.
    Kajiwara T, Tomita Y, Okano S, Iwai T, Yasunami Y, Yoshikai Y, Nomoto K, Yasui H, Tominaga R.
    Transplantation; 2007 Jan 27; 83(2):184-92. PubMed ID: 17264815
    [Abstract] [Full Text] [Related]

  • 13. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells.
    Kitamura H, Ohta A, Sekimoto M, Sato M, Iwakabe K, Nakui M, Yahata T, Meng H, Koda T, Nishimura S, Kawano T, Taniguchi M, Nishimura T.
    Cell Immunol; 2000 Jan 10; 199(1):37-42. PubMed ID: 10675273
    [Abstract] [Full Text] [Related]

  • 14. Regulatory natural killer T cells protect against spontaneous and recurrent type 1 diabetes.
    Sharif S, Arreaza GA, Zucker P, Delovitch TL.
    Ann N Y Acad Sci; 2002 Apr 10; 958():77-88. PubMed ID: 12021086
    [Abstract] [Full Text] [Related]

  • 15. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
    Cardell SL.
    Clin Exp Immunol; 2006 Feb 10; 143(2):194-202. PubMed ID: 16412042
    [Abstract] [Full Text] [Related]

  • 16. Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.
    Fujii S, Shimizu K, Kronenberg M, Steinman RM.
    Nat Immunol; 2002 Sep 10; 3(9):867-74. PubMed ID: 12154358
    [Abstract] [Full Text] [Related]

  • 17. Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
    Burdin N, Brossay L, Koezuka Y, Smiley ST, Grusby MJ, Gui M, Taniguchi M, Hayakawa K, Kronenberg M.
    J Immunol; 1998 Oct 01; 161(7):3271-81. PubMed ID: 9759842
    [Abstract] [Full Text] [Related]

  • 18. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.
    Singh N, Hong S, Scherer DC, Serizawa I, Burdin N, Kronenberg M, Koezuka Y, Van Kaer L.
    J Immunol; 1999 Sep 01; 163(5):2373-7. PubMed ID: 10452969
    [Abstract] [Full Text] [Related]

  • 19. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
    Bharhani MS, Chiu B, Na KS, Inman RD.
    Int Immunol; 2009 Jul 01; 21(7):859-70. PubMed ID: 19477915
    [Abstract] [Full Text] [Related]

  • 20. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes.
    Trembleau S, Penna G, Gregori S, Gately MK, Adorini L.
    Eur J Immunol; 1997 Sep 01; 27(9):2330-9. PubMed ID: 9341777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.